Kodiak Sciences Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
KOD$108.06+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Operations and Comprehensive Loss
| Year Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating expenses | |||
| Research and development | $182,373 | $126,095 | $206,298 |
| General and administrative | 52,015 | 60,754 | 71,023 |
| Total operating expenses | 234,388 | 186,849 | 277,321 |
| Loss from operations | (234,388) | (186,849) | (277,321) |
| Interest income | 4,517 | 11,148 | 16,733 |
| Interest expense | — | — | (13) |
| Other income (expense), net | (96) | (506) | 110 |
| Net loss | $(229,967) | $(176,207) | $(260,491) |
| Net loss per share, basic and diluted | $(4.32) | $(3.35) | $(4.97) |
| Weighted-average shares outstanding, basic and diluted | 53,208,311 | 52,583,148 | 52,414,256 |
| Other comprehensive income, net of tax | |||
| Change in unrealized gains on available-for-sale debt securities | — | — | 1,307 |
| Total other comprehensive income | — | — | 1,307 |
| Comprehensive loss | $(229,967) | $(176,207) | $(259,184) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.